Related Experiment Video
Updated: Feb 28, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
P450 engineering via structure-guided rational design achieves high C21-selectivity and bioconversion in steroid
Jian Yang1, Rong Li1, Qilin Gao1
1College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China.
Engineered a bacterial enzyme for efficient corticosteroid synthesis, achieving a regioselectivity shift for C21-hydroxylation of progesterone. This biocatalyst offers enhanced steroid production and insights into enzyme engineering.
Area of Science:
- Biocatalysis and Enzyme Engineering
- Synthetic Chemistry
- Molecular Biology
Background:
- C21-hydroxylation is a critical step in synthesizing corticosteroids like cortisol and aldosterone.
- The enzyme CYP154C5 from Nocardia farcinica is a potential candidate for this biotransformation.
- Engineering P450 enzymes is essential for improving their efficiency and selectivity in steroid synthesis.
Purpose of the Study:
- To engineer a highly efficient and regioselective C21-hydroxylase for progesterone (PRO) conversion.
- To enhance the catalytic activity and substrate scope of the engineered enzyme.
- To elucidate the structural basis for the observed regioselectivity shift using computational methods.
Main Methods:
- Structure-guided rational design and focused rational iterative site-directed mutagenesis (FRISM) were employed to engineer wild-type CYP154C5.
- A redox fusion variant (M6a-RhFRED L3) was constructed to enhance catalytic performance.
- Molecular docking and molecular dynamics (MD) simulations were used to analyze substrate binding and active site dynamics.
Main Results:
- The engineered variant M6a exhibited a complete shift in regioselectivity from C16α to C21 hydroxylation of PRO, with 98% selectivity and >99% conversion.
- The M6a-RhFRED L3 variant showed a 1.43-fold improvement in catalytic activity compared to M6a-RhFRED.
- M6a-RhFRED L3 successfully catalyzed the C21-hydroxylation of three steroid analogs with 98% selectivity and >60% conversion.
Conclusions:
- The engineered M6a variant and its redox fusion derivative M6a-RhFRED L3 are highly efficient biocatalysts for steroid C21-hydroxylation.
- Key residue modifications are crucial for modulating P450 enzyme regioselectivity, enabling a shift from C16α to C21 hydroxylation.
- This study provides valuable insights for the rational engineering of P450 enzymes for industrial applications in steroid synthesis.
More Related Videos
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Drug Metabolism: Phase I Reactions
Drug Biotransformation: Overview
Prodrugs
Prodrugs help overcome...
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...

